MedPharma USA
Brimonidine Tartrate Ophthalmic Solution 0.2%, 5mL, Bausch + Lomb
Brimonidine Tartrate Ophthalmic Solution 0.2%, 5mL, Bausch + Lomb
Buy at discounted prices
| Minimum Qty | Discount | 
|---|---|
| 5 + | 10% off | 
| 8 + | 12% off | 
| 10 + | 15% off | 
Couldn't load pickup availability
Brimonidine Tartrate Ophthalmic Solution 0.2%, 5mL, Bausch + Lomb
Brimonidine Tartrate Ophthalmic Solution 0.2% (5ml Bottle) is a prescription eye drop formulated to effectively manage intraocular pressure (IOP) in patients diagnosed with open-angle glaucoma or ocular hypertension. This fast-acting ophthalmic solution is clinically validated to reduce IOP, thereby helping to prevent optic nerve damage and mitigate the risk of visual field loss.
Key Features:
- Active Ingredient: Brimonidine Tartrate 2 mg/mL (0.2%)
 - Purpose: Reduces intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension
 - Fast-Acting: Provides IOP-lowering effects within hours of administration
 - Prescription Required: Available only through a licensed healthcare provider
 - Bottle Size: 5mL
 - NDC Code: 0023-0140-05
 
Indications for Use:
Brimonidine Tartrate Ophthalmic Solution is indicated for:
- Management of open-angle glaucoma
 - Treatment of ocular hypertension
 
Note: The IOP-lowering effect may diminish over time, necessitating regular monitoring by a qualified eye care professional.
Dosage & Administration:
The recommended dosage is one drop in the affected eye(s) three times daily, spaced approximately 8 hours apart. To ensure proper administration, follow these steps:
- Thoroughly wash hands before use.
 - Tilt the head back and gently pull down the lower eyelid.
 - Instill one drop into the affected eye(s).
 - Close the eyes and apply gentle pressure to the inner corner of the eye for 1-2 minutes.
 - Wait at least 5 minutes before administering any other ocular medications.
 
Warnings & Precautions:
Use Brimonidine Tartrate with caution if the patient has:
- Vascular insufficiency or severe cardiovascular conditions
 - Potential central nervous system (CNS) effects, such as drowsiness or dizziness
 - A history of allergic reactions to any components in this formulation
 
Adverse Reactions:
Common side effects (occurring in 10-30% of patients) include:
- Oral dryness
 - Eye redness
 - Burning or stinging sensation
 - Blurred vision
 
Less common reactions might occur; discontinue use and seek medical assistance for severe side effects.
Storage Requirements:
Store Brimonidine Tartrate Ophthalmic Solution 0.2% at a temperature of 15°C to 25°C (59°F to 77°F). Ensure the bottle is tightly sealed when not in use and protect it from light and moisture.
Important Notice:
This product is prescription-only and designated for topical ophthalmic application. Proper administration is essential for maintaining ocular health and effectively managing intraocular pressure.
Order Now:
Ensure consistent control of intraocular pressure and protect eye health by ordering Brimonidine Tartrate Ophthalmic Solution 0.2% (5ml Bottle) today!
Share
